Teva Pharmaceutical Indus... (TEVA)

NYSE: TEVA · Real-Time Price · USD

15.63

0.12 (0.77%)

At close: May 01, 2025, 3:59 PM

15.60

-0.22%

After-hours: May 01, 2025, 07:47 PM EDT

Teva Pharmaceutical Industries Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-1.96B	-615M	-2.41B	456M	-4.1B	76M	-2.47B	-16.45B	311M
Depreciation & Amortization	1.06B	1.15B	1.31B	1.33B	1.56B	416M	1.84B	2.11B	1.52B
Stock-Based Compensation	123M	121M	124M	119M	129M	20M	155M	133M	124M
Other Working Capital	-1.1B	-1.67B	-828M	-2.27B	-1.47B	-632M	-1.44B	1.32B	-1.03B
Other Non-Cash Items	3.09B	1.1B	2.37B	714M	6.51B	471M	5.58B	20.41B	2.03B
Deferred Income Tax	-634M	-317M	-1.06B	-120M	-696M	-333M	-837M	-2.33B	15M
Change in Working Capital	-435M	-72M	1.26B	-1.7B	-2.19B	-112M	-1.82B	-363M	1.22B
Operating Cash Flow	1.25B	1.37B	1.59B	798M	1.22B	538M	2.45B	3.51B	5.22B
Capital Expenditures	-498M	-526M	-548M	-562M	-578M	-119M	-651M	-874M	-901M
Cash Acquisitions	-15M	68M	61M	1.96B	67M	-343M	1.74B	43M	-36.15B
Purchase of Investments	-71M	-46M	-1M	-47M	-55M	-3M	-119M	-200M	-481M
Sales Maturities Of Investments	40M	n/a	4M	172M	12M	343M	890M	3.48B	2B
Other Investing Acitivies	1.34B	1.47B	1.14B	1M	1.42B	552M	11M	3.19B	1.79B
Investing Cash Flow	792M	968M	656M	1.52B	863M	430M	1.87B	2.16B	-35.74B
Debt Repayment	-1.64B	-1.7B	-1.37B	-2.17B	-1.88B	-1.86B	-3.27B	-4.48B	26.25B
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-52M	-22M	-1.16B	-1.56B
Other Financial Acitivies	-150M	-212M	-118M	-6M	-5M	-11M	-57M	-112M	-134M
Financial Cash Flow	-1.79B	-1.91B	-1.49B	-2.17B	-1.89B	-241M	-3.35B	-5.75B	25.22B
Net Cash Flow	73M	393M	636M	21M	202M	734M	819M	-25M	-5.96B
Free Cash Flow	749M	842M	1.04B	236M	638M	419M	1.79B	2.63B	4.32B